Personalized breast cancer therapy: A new treatment approach for patients with limited tamoxifen efficacy
Peer-Reviewed Publication
Updates every hour. Last Updated: 9-Nov-2025 13:11 ET (9-Nov-2025 18:11 GMT/UTC)
The Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology in Stuttgart has developed a pioneering therapeutic approach for breast cancer patients who respond poorly to the standard drug tamoxifen. The innovative combination therapy has been successfully tested in a clinical trial under the name TAMENDOX. The results have now been published in the renowned journal Clinical Cancer Research. The project was funded by the German Federal Ministry of Research, Technology, and Space.
Without proper vascular systems — even primitive ones — engineered tissue faces restricted size and functionality, even developing necrotic regions of dead cells. New research from Binghamton University’s Thomas J. Watson College of Engineering and Applied Science offers a possible solution to the problem.
The Israel Science Foundation (ISF) recently published the list of individual research grant winners for the 2024-2025 academic year. ISF grants are awarded on the basis of scientific excellence and project quality in the fields of exact sciences and technology, life sciences and medicine, and the humanities and social sciences.
The U.S.-Israel Binational Science Foundation, which promotes scientific research ties between the United States and Israel, recently announced the recipients of individual research grants for 2024–2025.
Two researchers from Reichman University were awarded the prestigious grant:
Prof. Gurit Birnbaum of the Baruch Ivcher School of Psychology and Prof. Gili Kalai of the Efi Arazi School of Computer Science
Single-photon sources are key components of quantum communication technologies. However, conventional designs use decoupled single-photon emitters and photon transmission methods, resulting in high transmission loss, limiting practical applicability. Now, researchers from Japan have developed a new method, where a single rare-earth ion is used to generate and guide single photons directly within an optical fiber at room temperature. It is low cost and can become a key component of upcoming quantum communication technologies.